Insulet
PODD
#2033
Rank
โ‚น889.39 B
Marketcap
โ‚น12,821
Share price
-1.81%
Change (1 day)
-56.59%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): โ‚น556.46

According to Insulet's latest financial reports the company's current EPS (TTM) is โ‚น554.08. In 2024 the company made an earnings per share (EPS) of โ‚น557.81 an increase over its 2023 EPS that were of โ‚น275.18.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น556.46
2024โ‚น557.81102.71%
2023โ‚น275.184114.29%
2022โ‚น6.53-69.57%
2021โ‚น21.45109.09%
2020โ‚น10.26-38.89%
2019โ‚น16.79200%
2018โ‚น5.60-113.04%
2017-โ‚น42.91-9.8%
2016-โ‚น47.57-60.47%
2015-โ‚น120.3338.71%
2014-โ‚น86.7512.05%
2013-โ‚น77.42-23.15%
2012-โ‚น100.74-12.2%
2011-โ‚น114.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น623.09 12.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น252.22-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚น380.58-31.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
โ‚น2,881 420.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-โ‚น86.75-115.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
โ‚น111.94-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
โ‚น241.60-56.40%๐Ÿ‡บ๐Ÿ‡ธ USA